The risk for myocardial infarction with cyclooxygenase-2 inhibitors.

Ken Shinmura, Roberto Bolli

Research output: Contribution to journalComment/debate

Original languageEnglish (US)
Pages (from-to)617; author reply 617-618
JournalAnnals of internal medicine
Volume143
Issue number8
DOIs
StatePublished - Oct 18 2005

ASJC Scopus subject areas

  • Internal Medicine

Cite this